# Macrophages expressing macrophage receptor with collagen structure attenuate liver fibrosis through a tissue restoration phenotype

**Authors:** Sofia Jerez, Shawna A. Cooper, Usman Yaqoob, Maleeha F. Kalaiger, Abid A. Anwar, Mandy Wong, Bushra Arif, Luke C. Doskey, Maria Hernandez-Tejero, William A. Sherman, Ruben De Boeck, Ying Li, Moira B. Hilscher, Enis Kostallari, Nidhi Jalan-Sakrikar, Sheng Cao, Vijay H. Shah

PMC · DOI: 10.1172/jci.insight.193172 · JCI Insight · 2026-03-23

## TL;DR

Macrophages expressing MARCO reduce liver scarring by promoting tissue repair and reducing inflammation in a mouse model of liver fibrosis.

## Contribution

MARCO+ macrophages are shown to have a tissue restorative role in liver fibrosis through interaction with hepatic stellate cells.

## Key findings

- MARCO+ macrophages reduce collagen deposition and ECM-associated gene expression in hepatic stellate cells.
- MARCO expression in macrophages promotes anti-inflammatory and antifibrotic gene expression and enhances phagocytosis.
- Adoptive transfer of MARCO+ macrophages attenuates liver fibrosis in a mouse model.

## Abstract

Liver macrophages are central in maintaining hepatic homeostasis and mediating immune responses during liver injury, including fibrosis. Macrophages may have proinflammatory or antiinflammatory properties, but which properties influence fibrosis remains unclear. To explore the role of macrophages in liver fibrosis, we performed single-cell RNA-seq in a mouse model of liver injury and found that macrophage diversity was increased. Marco was among the most significantly upregulated genes, and a population of Marcohi macrophages increased with injury and spatially segregated to nonfibrotic areas. The macrophage receptor with collagenous structure (MARCO) protein is a scavenger receptor expressed by specific subsets of macrophages, and its role in liver fibrosis is unclear. In vitro induction of Marco in bone marrow–derived macrophages decreased proinflammatory gene expression, increased antiinflammatory and antifibrotic gene expression, and enhanced phagocytosis, indicating a restorative phenotype. Adoptive transfer of MARCO+ macrophages in a mouse model of liver fibrosis reduced the expression of extracellular matrix–associated (ECM-associated) genes in hepatic stellate cells (HSCs) and reduced collagen deposition, which did not occur with the transfer of MARCO– macrophages. Therefore, MARCO+ macrophages have a tissue restorative role in the liver and attenuate fibrogenesis through interaction with HSCs, thereby providing a potential therapeutic pathway for liver fibrosis.

Injection of bone marrow-derived macrophages (BMDM) expressing Macrophage receptor with a collagenous structure (MARCO) reduces scarring in a mouse model of chronic liver fibrosis.

## Linked entities

- **Genes:** MARCO (macrophage receptor with collagenous structure) [NCBI Gene 8685]
- **Proteins:** MARCO (macrophage receptor with collagenous structure)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ecm1 (extracellular matrix protein 1) [NCBI Gene 13601] {aka p85}, Cd63 (CD63 antigen) [NCBI Gene 12512] {aka ME491, Tspan30}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Marco (macrophage receptor with collagenous structure) [NCBI Gene 17167] {aka Ly112, Scara2}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Eln (elastin) [NCBI Gene 13717] {aka E030024M20Rik}, Gem (GTP binding protein overexpressed in skeletal muscle) [NCBI Gene 14579], Gpnmb (glycoprotein (transmembrane) nmb) [NCBI Gene 93695] {aka DC-HIL, Dchil, ipd}, Ccr5 (C-C motif chemokine receptor 5) [NCBI Gene 12774] {aka AM4-7, CD195, Cmkbr5}, Reln (reelin) [NCBI Gene 19699] {aka reeler, rl}, Cxcr3 (C-X-C motif chemokine receptor 3) [NCBI Gene 12766] {aka Cd183, Cmkar3}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Ccr7 (C-C motif chemokine receptor 7) [NCBI Gene 12775] {aka CC-CKR-7, CCR-7, CD197, Cdw197, Cmkbr7, EBI1}, Mmp12 (matrix metallopeptidase 12) [NCBI Gene 17381] {aka MME, Mmel}, Des (desmin) [NCBI Gene 13346], Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Dcn (decorin) [NCBI Gene 13179] {aka DC, DSPG2, PG40, PGII, PGS2, SLRR1B}, Clec4f (C-type lectin domain family 4, member f) [NCBI Gene 51811] {aka Clecsf13, KUCR_MOUSE, Kclr}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, Dsp (desmoplakin) [NCBI Gene 109620] {aka 2300002E22Rik, 5730453H04Rik, DP, rul}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** injured liver (MESH:D017093), Chronic liver diseases (MESH:D008107), fatty liver (MESH:D005234), inflammation (MESH:D007249), Chronic liver fibrosis (MESH:D008103), autoimmune diseases (MESH:D001327), NPC (MESH:D052556), Cancer (MESH:D009369), Fibrosis (MESH:D005355), multiple sclerosis (MESH:D009103), intrahepatic (MESH:D002780), chronic (MESH:D002908), spinal cord injury (MESH:D013119), cirrhotic (MESH:D000094724), rheumatoid arthritis (MESH:D001172), lung diseases (MESH:D008171), Diabetes (MESH:D003920), death (MESH:D003643), Digestive and Kidney Diseases (MESH:D007674), tumorigenesis (MESH:D063646), SAC (MESH:D010698), autoimmune encephalomyelitis (MESH:D004681)
- **Chemicals:** CO2 (MESH:D002245), DPBS (MESH:C012939), LPS (MESH:D008070), Clodronate (MESH:D004002), CCl4 (MESH:D002251), NaCl (MESH:D012965), paraffin (MESH:D010232), Formalin (MESH:D005557), PI (MESH:D010716), PBS (MESH:D007854), Olive Oil (MESH:D000069463), penicillin (MESH:D010406), Picrosirius red (MESH:C009798), ampicillin (MESH:D000667), alcohol (MESH:D000438), EDTA (MESH:D004492), amphotericin B (MESH:D000666), latex (MESH:D007840), CLD-8901 (-), streptomycin (MESH:D013307), hydroxyproline (MESH:D006909)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C for 16-24, C3040H, S11150H
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), BMDM — Homo sapiens (Human), Finite cell line (CVCL_6F32), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043091/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043091/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043091/full.md

---
Source: https://tomesphere.com/paper/PMC13043091